| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Arcadia Biosciences, Inc. | Chief Financial Officer | Common Stock | 2,681 | $6,676 | $2.49 | 03 Feb 2025 | Direct |
| Arcadia Biosciences, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 33,987 | 09 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RKDA | Arcadia Biosciences, Inc. | 09 May 2025 | 1 | $0 | 4 | Chief Financial Officer | 12 May 2025, 20:56 |
| RKDA | Arcadia Biosciences, Inc. | 03 Feb 2025 | 1 | +$1,743 | 4 | Chief Financial Officer | 05 Feb 2025, 19:34 |
| RKDA | Arcadia Biosciences, Inc. | 19 Aug 2024 | 1 | $0 | 4 | Chief Financial Officer | 21 Aug 2024, 18:26 |
| RKDA | Arcadia Biosciences, Inc. | 01 Aug 2024 | 1 | +$1,442 | 4 | Chief Financial Officer | 20 Aug 2024, 20:11 |
| RKDA | Arcadia Biosciences, Inc. | 05 Jul 2024 | 0 | $0 | 3 | Chief Financial Officer | 18 Jul 2024, 16:22 |